Infinite Roots (formerly Mushlabs) is a German biotech company developing products from fungal mycelium for applications ranging from food to materials. The company closed a $58M Series B to accelerate commercial growth and expand production capacity. IR plans to use the capital to invest in launch activities and scale using an asset-light production approach. That approach includes partnering with existing industrial facilities and refurbishing parts of a large German brewery to use brewery capacity and waste as a production hub. The firm faces well-funded competitors in the mycelium space, including Meati, Nature’s Fynd, Myco Technology, Enough, and Quorn. Founder and CEO Dr. Mazen Rizk said the funding reflects the company’s ability to scale its technology toward industrial production. Mushlabs develops liquid-fermentation processes to grow edible mushroom mycelium for use in alternative-protein and meat-replacement products. Its mycelia are fed on agrifood sidestreams, producing biomass in four to five days and enabling a highly circular, lower-water, lower-footprint process. The startup highlights nutritional benefits (protein, micronutrients, fiber with prebiotic properties) and a cleaner label versus some competitors, using recognizable edible mushroom varieties. Mushlabs sees potential for decentralized, mobile production that can operate year-round and support localized food supply during crises. Since launching in mid-2018 the company has built an 11-person team with experience at Unilever and Marley Spoon. It plans to use new capital to scale to industrial production, build a sales function, and is considering consumer-facing offerings.

Total raised

$68M

Funding rounds

2

Latest round

Series B

Latest activity

Jan 2024